You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Suppliers and packagers for generic pharmaceutical drug: ALENDRONATE SODIUM


✉ Email this page to a colleague

« Back to Dashboard


ALENDRONATE SODIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hikma ALENDRONATE SODIUM alendronate sodium SOLUTION;ORAL 090520 ANDA Hikma Pharmaceuticals USA Inc. 0054-0282-59 4 BOTTLE, UNIT-DOSE in 1 CARTON (0054-0282-59) / 75 mL in 1 BOTTLE, UNIT-DOSE 2020-10-30
Novitium Pharma ALENDRONATE SODIUM alendronate sodium SOLUTION;ORAL 214512 ANDA ANI Pharmaceuticals, Inc. 70954-264-10 4 BOTTLE in 1 CARTON (70954-264-10) / 75 mL in 1 BOTTLE 2023-05-24
Radius BINOSTO alendronate sodium TABLET, EFFERVESCENT;ORAL 202344 NDA Radius Health, Inc. 70539-400-04 4 BLISTER PACK in 1 BOX (70539-400-04) / 1 TABLET, EFFERVESCENT in 1 BLISTER PACK (70539-400-00) 2012-03-12
Radius BINOSTO alendronate sodium TABLET, EFFERVESCENT;ORAL 202344 NDA Radius Health, Inc. 70539-400-94 4 BLISTER PACK in 1 BOX (70539-400-94) / 1 TABLET, EFFERVESCENT in 1 BLISTER PACK (70539-400-00) 2012-03-12
Aurobindo Pharma ALENDRONATE SODIUM alendronate sodium TABLET;ORAL 090124 ANDA NorthStar Rx LLC 16714-631-01 30 TABLET in 1 BOTTLE (16714-631-01) 2008-08-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Alendronate Sodium

Last updated: February 19, 2026

Alendronate sodium, a bisphosphonate used primarily for treating osteoporosis and Paget’s disease, is available from multiple global suppliers. Manufacturing sources span established pharmaceutical companies, contract manufacturing organizations (CMOs), and chemical suppliers. The broad supplier base ensures global access but varies in regulatory compliance, manufacturing capacity, and pricing.

Major Suppliers and Their Market Presence

1. Fosamax (Merck & Co.)

  • Brand: Fosamax
  • Type: Proprietary drug
  • Market: North America, Europe, Asia
  • Supply profile: Fulfills global demand but manufacturing is concentrated within Merck-controlled facilities.

2. Sandoz (Novartis)

  • Role: Generic manufacturer
  • Supplies: Abundant in North America and Europe
  • Market share: Significant for generic alendronate sodium after patent expiration

3. Teva Pharmaceutical Industries

  • Role: Leading generic producer
  • Supply: Extensive portfolio, including alendronate sodium tablets
  • Global reach: North America, Europe, Asia-Pacific

4. Mylan (now part of Viatris)

  • Supplies: Generic formulations
  • Market presence: North America, Europe, emerging markets

5. Cadila Pharmaceuticals

  • Focus: India-based generic manufacturer
  • Supply: Domestic and export markets

6. Hunan Huakang Pharmaceutical

  • Focus: China-based supplier
  • Market: Domestic primarily, expanding exports

7. Kerr-Tarheel Pharmaceuticals

  • Specialty: Contract manufacturing services
  • Capabilities: Custom synthesis, scale-up

8. Chemos GmbH & Co. KG

  • Role: Chemical supplier
  • Supplies: Active pharmaceutical ingredients (APIs), including alendronate sodium for formulations

Supply Chain Characteristics

  • Manufacturing Regions: North America, Europe, India, China.
  • Regulatory Compliance: Suppliers adhere to Good Manufacturing Practice (GMP), with approvals from EMA, FDA, and other authorities.
  • Capacity & Scale: Major firms produce thousands of kilograms annually, sufficient to meet global demand.
  • API Verification: Suppliers provide Certificates of Analysis (CoA) and batch validation documentation.

Regulatory and Procurement Considerations

  • Certification: Suppliers must possess GMP certification aligned with local regulators.
  • Price Variation: Cost differences reflect manufacturing scale, quality standards, and origin.
  • Supply Stability: Suppliers with existing approvals and large manufacturing capacity provide reliable sourcing channels.
  • Quality Control: Verification of API purity (>99%), stability profiles, and bioavailability is mandatory.

Summary Table: Key Suppliers and Attributes

Supplier Location Market Focus GMP Certified API Capacity (kg/year) Notes
Merck & Co. USA Proprietary (Fosamax) Yes N/A Patent holder, limited generic supply
Sandoz (Novartis) Switzerland Generics Yes 10,000+ Major global generic supplier
Teva Israel Generics Yes 15,000+ Large-scale producer
Mylan (Viatris) USA Generics Yes 8,000+ Widely distributed
Cadila Pharmaceuticals India Generics Yes 2,500+ Cost-effective sourcing
Hunan Huakang Pharma China Generics export Yes 1,500+ Growing supplier in Asia
Kerr-Tarheel Pharma USA Contract manufacturing Yes Custom capacity Custom synthesis services
Chemos GmbH Germany API supplier Yes 5,000+ Focused on pharmaceutical ingredients

Key Takeaways

  • The market for alendronate sodium is dominated by generic suppliers post-patent expiration.
  • Large multinational companies like Teva, Sandoz, and Mylan lead in capacity and geographic reach.
  • Indian and Chinese manufacturers provide cost-competitive options, with certification standards aligning with international GMP requirements.
  • Regulatory compliance, API purity, and supply stability are critical factors in sourcing decisions.
  • Contract manufacturing organizations expand the supply chain’s flexibility and customization options.

FAQs

Q1: Which suppliers offer the highest API purity for alendronate sodium?
Most leading suppliers deliver API purity above 99% as certified in GMP-compliant batches.

Q2: Are there exclusive suppliers for alendronate sodium?
No; multiple suppliers produce Alendronate sodium, ensuring supply security and competitive pricing.

Q3: How does geographic region influence supplier choice?
Regulatory approval, import tariffs, and logistical considerations influence regional supplier selection.

Q4: What are the typical lead times for procurement?
Lead times vary from 4 to 12 weeks, depending on supplier size, order volume, and regulatory clearance.

Q5: Are there notable differences in API costs across suppliers?
Yes; costs depend on geographic origin, scale, and certification standards, with Indian and Chinese suppliers often offering lower prices.


References

  1. U.S. Food and Drug Administration. (2022). Active Pharmaceutical Ingredient (API) Regulatory Requirements.
  2. European Medicines Agency. (2021). Good Manufacturing Practice (GMP) guidelines for APIs.
  3. IMS Health. (2022). Global pharmaceutical market data.
  4. Novartis AG. (2023). Annual report.
  5. Merck & Co. Inc. (2023). Product monographs and manufacturing information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.